New Wound-Cleaning pad tested for safety and performance
NCT ID NCT07255937
First seen Jun 27, 2026 · Last updated Jul 09, 2026 · Updated 2 times
Summary
This study is testing a pad used to clean wounds, such as diabetic ulcers, leg ulcers, pressure sores, surgical wounds, and burns. The goal is to see if the pad safely removes debris and improves the wound bed right after use. About 184 adults with these types of wounds will take part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
184 people
The number who actually took part.
- Started
-
Nov 2025
- Finished
-
Mar 2026
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Males or females aged 18 years or above. * Patients who can understand and give informed consent to take part in the study. * Have one or more of the following wounds: Diabetic ulcers, Arterial and Venous Leg ulcers, Pressure ulcers, Postoperative wounds healing by secondary intention, traumatic and surgical wounds, and burns and scalds * Wounds that require debridement due to the presence of slough debris/fibrous tissue ,hyperkeratotic debris and dried exudate on the peri wound skin. * Wounds with both serous crusts and healthy tissue. * Minimum of 30% of the wound covered by debris, necrosis or slough. * Wound Size \> 4cm2 Exclusion Criteria: * Patients who are known to be non-compliant with medical treatment * Patients who are known to be sensitive to any of the device components such as polyester. * Subject has any significant or unstable medical or psychiatric condition that, in the opinion of the Investigator, would interfere with their ability to participate in the study. * Subject is currently enrolled in another clinical study, or has completed a clinical study less than 30 days prior to enrolment. * Symptoms \& signs of systemic and / or spreading wound infection (including erythema and fever). * Severe pain (level 7 or higher on a 0-10 VAS or hyperaesthesia in the wound area). * Subjects who in the view of the investigator might not be suitable for inclusion in the study
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Arterial leg ulcer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Clínica Cres
Madrid, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Cameras and ultrasound could take the guesswork out of wound care
- Zapping a leg nerve: can a wearable device help stubborn ulcers heal?
- Wound dressings that trap microbes: scientists test a Drug-Free approach
- Could a scent soothe burn pain in kids?
- Light therapy put to the test for stubborn leg wounds
- 3D-Printed dental guide aims to boost precision in Root-End surgery